07/06/2024
In June, one of the most significant events for biotechnology worldwide companies, the BIO2024 “Bio International Convention”, took place in San Diego, USA.
Mikrobiomik was honored with dual participation at this prestigious event. After several stages of pre-selection, we were chosen as one of the 40 finalists to pitch at the Start-Up Stadium within the Platform for Therapeutics. The presentation, held before a full audience, was a resounding success.
Furthermore, Mikrobiomik hosted an engaging booth that attracted a steady stream of attendees eager to learn about microbiota and our latest advancements in developing biologic therapies based on gut microbiota.
Our stellar team, including members of our business development division and our CEO, represented Mikrobiomik with distinction. Providing in-depth insights into our research, pipeline, and innovations, fostering valuable connections with industry leaders. Overall, BIO2024 was a remarkable opportunity for Mikrobiomik to showcase our pioneering work and strengthen our position in the biotech industry.
